Bridgewater, NJ - The FDA has approved a supplemental new drug application (sNDA) regarding the use of enoxaparin (Lovenox ®, Aventis) antithrombotic therapy in patients with mechanical prosthetic ...

The US Food and Drug Administration (FDA) today released a drug safety advisory with recommendations aimed at reducing the risk of spinal column bleeding after spinal intervention, including epidural ...

If you have deep vein thrombosis or a pulmonary embolism, or if you had a certain kind of heart attack (among other conditions), your doctor may prescribe the blood thinner enoxaparin (Lovenox), per ...

(Reuters) - The U.S. Food and Drug Administration issued a new warning on the use of the anticoagulant Lovenox in patients fitted with a spinal catheter because of the risk of spinal column bleeding ...

Abdominal surgery for cancer carries a high risk of venous thromboembolism, but the optimal duration of postoperative thromboprophylaxis is unknown. We conducted a double-blind, multicenter trial in ...

GlaxoSmithKline is upping the ante in its bid to win market share from Sanofi-Aventis’ number one clotbusting drug, Lovenox (enoxaparin), and yesterday unveiled data at the European Society of ...